Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials.

Malaria journal - 17 Aug 2011

Carter Nick, Pamba Allan, Duparc Stephan, Waitumbi John N

Abstract excerpt

BACKGROUND: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is common in populations living in malaria endemic areas. G6PD genotype and phenotype were determined for malaria patients enrolled in the chlorproguanil-dapsone-artesunate (CDA) phase III clinical trial programme. METHODS: Study participants, aged > 1 year, with microscopically confirmed uncomplicated Plasmodium falciparum malaria, and haemoglobin ≥...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimalarials
Share to Artemisinins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Artesunate

Share to Dapsone

Share to Drug Combinations

Share to Glucosephosphate Dehydrogenase

Share to Glucosephosphate Dehydrogenase Deficiency

Share to Proguanil

Source

Open in PubMed Open full text

Identifiers

PMID: 21849081
DOI: 10.1186/1475-2875-10-241
PMCID: PMC3188486

Genes

CDA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials.PMID 21849081Read ↗

Genotypic glucose-6-phosphate dehydrogenase (G6PD) deficiency protects against Plasmodium falciparum infection in individuals living in Ghana.Semantic proximity Read ↗

Glucose-6-phosphate dehydrogenase deficiency and reduced haemoglobin levels in African children with severe malaria.Semantic proximity Read ↗

The prevalence of glucose-6-phosphate dehydrogenase deficiency in Gambian school children.Semantic proximity Read ↗

Low and heterogeneous prevalence of glucose-6-phosphate dehydrogenase deficiency in different settings in Ethiopia using phenotyping and genotyping approaches.Semantic proximity Read ↗

Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa.Semantic proximity Read ↗

Prevalence of glucose-6-phosphate dehydrogenase deficiency and its association with Plasmodium falciparum infection among children in Iganga distric in Uganda.Semantic proximity Read ↗

G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.Semantic proximity Read ↗

G6PD deficiency: global distribution, genetic variants and primaquine therapy.Semantic proximity Read ↗

Spatial distribution of G6PD deficiency variants across malaria-endemic regions.Semantic proximity Read ↗

Glucose-6-phosphate dehydrogenase deficient variants are associated with reduced susceptibility to malaria in the Brazilian Amazon.Semantic proximity Read ↗

Wide range of G6PD activities found among ethnic groups of the Chittagong Hill Tracts, BangladeshSemantic proximity Read ↗

Prevalence of G6PD deficiency and distribution of its genetic variants among malaria-suspected patients visiting Metehara health centre, Eastern EthiopiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.